The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults ...
A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds.
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
We hope you have a smashing day and conquer the world. And do keep in touch. … Martin Makary, President-elect Trump’s pick to ...
As many as 136 million adult Americans may be eligible for Ozempic, researchers estimate. According to a study published ...
CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible ...
Japanese researchers say they have found a pill that works as well as existing medication to prevent blood clots afte ...
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...
Unlike VKA warfarin, tecarfarin uses a unique metabolic pathway that is less affected by drug-drug interactions and kidney impairment. By providing a stable, once-daily, and reversible therapeutic, ...
People on blood thinners have a doubled risk of dangerous internal bleeding if they also take a non-steroidal ...
7d
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback